RecruitingPhase 3NCT06247839

The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder


Sponsor

Sharmin Ghaznavi

Enrollment

20 participants

Start Date

Sep 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This open-label functional Magnetic Resonance Imaging (fMRI) study will assess the effects of a single dose of psilocybin on rumination and the neural correlates of rumination in individuals with major depressive disorder.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study explores how psilocybin (the active compound in certain mushrooms) affects the way people with depression think about themselves. Researchers believe that depression involves too much negative self-focused thinking, and psilocybin may help shift that pattern. Participants will receive psilocybin in a controlled, supervised clinical setting. **You may be eligible if...** - You are between 18 and 55 years old - You have been diagnosed with moderate or greater major depressive disorder - Your depression has lasted at least 3 months - You score at least 18 on a standard depression scale - You are able to give informed consent **You may NOT be eligible if...** - You have a personal or family history of psychosis, schizophrenia, or bipolar disorder - You are currently taking certain psychiatric medications - You have active suicidal intent - You have a serious heart condition or other major medical illness - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPsilocybin

COMP360 (Brand name of psilocybin to be used)


Locations(1)

Athinoula A. Martinos Center for Biomedical Imaging

Charlestown, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06247839


Related Trials